Definium Therapeutics reports positive Phase 3 Panorama results for DT120 ODT

Definium Therapeutics reported positive topline Phase 3 Panorama results for DT120 ODT in generalized anxiety disorder, its third positive Phase 3 trial, with the stock moving sharply in premarket trading.

Detected & updated continuously · Source: Nebula